Share on LinkedInShare on LinkedIn

ARTICLE · 24 APRIL 2017

Fed Circ Affirms Conflicting Invalidity Determinations From District Court And PTAB

Jones Day
Jones Day
Contributor
Jones Day

Jones Day

Jones Day is a global law firm with more than 2,400 lawyers in 40 offices across five continents....

View firm profile
Explore more from Jones Day

As we have previously discussed on this blog, when considering an issue of patentability such as definiteness under section 112, the PTAB and a district court may properly reach opposite conclusions.

United StatesIntellectual Property

As we have previously discussed on this blog, when considering an issue of patentability such as definiteness under section 112, the PTAB and a district court may properly reach opposite conclusions. In Tinnus Enterprises LLC v. Telebrands Corp., 846 F.3d 1190 (Fed. Cir. 2017), the PTAB and the district court reached opposite conclusions because each was applying a substantively different standard for indefiniteness, a practice the Federal Circuit has so far affirmed. However, even in instances where both the PTAB and the district court apply the same test, as in a section 103 obviousness analysis, different conclusions may properly be reached.

At issue in Novartis AG v. Noven Pharm. Inc., Appeal No. 16-1678, 2017 WL 1229742 (Fed. Cir. April 4, 2017) were two related PTAB decisions finding several asserted claims invalid as obvious under section 103. The PTAB's decisions ran counter to prior district court and Federal Circuit decisions finding the asserted claims not

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from